The store will not work correctly when cookies are disabled.
7-{[3-(4-(Trifluoromethyl)phenyl)-4,5-dihydro-1,2-oxazol-5-yl]methoxy}-4-methyl-2H-chromen-2-one
ID: ALA4748694
PubChem CID: 162650184
Max Phase: Preclinical
Molecular Formula: C21H16F3NO4
Molecular Weight: 403.36
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(=O)oc2cc(OCC3CC(c4ccc(C(F)(F)F)cc4)=NO3)ccc12
Standard InChI: InChI=1S/C21H16F3NO4/c1-12-8-20(26)28-19-10-15(6-7-17(12)19)27-11-16-9-18(25-29-16)13-2-4-14(5-3-13)21(22,23)24/h2-8,10,16H,9,11H2,1H3
Standard InChI Key: BZFNGKMYPVQKPK-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
28.6430 -28.7379 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
28.8576 -27.9496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0676 -28.1579 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
35.5216 -26.7939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5205 -27.6135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2285 -28.0224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2267 -26.3851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9354 -26.7903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9361 -27.6093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6447 -28.0164 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.3529 -27.6056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3482 -26.7835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6391 -26.3801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6348 -25.5629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0622 -28.0114 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.8125 -28.0215 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.1051 -27.6123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3970 -28.0204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6542 -27.6897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1069 -28.2966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5150 -29.0046 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.3144 -28.8352 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.2974 -28.2101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9664 -27.4618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1545 -27.3754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6728 -28.0366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0087 -28.7862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8196 -28.8689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5272 -27.2053 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 8 1 0
13 14 1 0
11 15 2 0
5 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 18 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
20 23 1 0
26 2 1 0
2 29 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 403.36 | Molecular Weight (Monoisotopic): 403.1031 | AlogP: 4.69 | #Rotatable Bonds: 4 |
Polar Surface Area: 61.03 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 1.97 | CX LogP: 4.55 | CX LogD: 4.55 |
Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.59 | Np Likeness Score: -0.76 |
References
1. Lingaraju GS,Balaji KS,Jayarama S,Anil SM,Kiran KR,Sadashiva MP. (2018) Synthesis of new coumarin tethered isoxazolines as potential anticancer agents., 28 (23-24): [PMID:30396758] [10.1016/j.bmcl.2018.10.046] |